previously number of years, the UK has witnessed a revolution in medical excess weight‑reduction treatment options — in the introduction of semaglutide (Wegovy®) to the developing level of popularity of tirzepatide (Mounjaro®). Now, another name is drawing interest in both of those medical and community overall health circles: Retatrutide. C